Anthrax Vaccine Adsorbed (Biothrax)
Anthrax Vaccine Adsorbed is an FDA-licensed reference biologic from Emergent BioDefense Operations Lansing LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1998
Reference approved
Reference product
Biothrax Anthrax Vaccine Adsorbed
Emergent BioDefense Operations Lansing LLC
- Approved
- Nov 12, 1998
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Anthrax Vaccine Adsorbed, in chronological order.
Reference approval
Approval date of the reference Anthrax Vaccine Adsorbed product.
27 yr 11 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
3 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Anthrax Vaccine Adsorbed (Biothrax)?
No 351(k) biosimilars or interchangeable biosimilars referencing Anthrax Vaccine Adsorbed are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.